Join
Live feed
·
INSIDERFilingvia Quantisnow
ACADIA Pharmaceuticals Inc. logo

EVP, CHIEF FINANCIAL OFFICER Schneyer Mark C. converted options into 19,826 shares and sold $172,454 worth of shares (10,259 units at $16.81), increasing direct ownership by 22% to 53,302 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ACAD· ACADIA Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ACAD (ACADIA Pharmaceuticals Inc.) and more on Quantisnow.

EVP, CHIEF FINANCIAL OFFICER Schneyer Mark C. converted options into 19,826 shares and sold $172,454 worth of shares (10,259 units at $16.81), increasing direct ownership by 22% to 53,302 units (SEC Form 4) | Quantisnow